ARTICLE | Finance
Grail’s Asia incentives
Why Hong Kong IPO could be sensible for Grail following $300M series C
May 25, 2018 5:40 PM UTC
In light of Grail Inc.’s $300 million series C round from Chinese investors, the cancer detection company has several reasons to pursue a Hong Kong listing that go beyond high valuations.
The series C round, announced on May 21, saw the company gain a bevy of new Chinese investors. ...
BCIQ Company Profiles